BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33318171)

  • 1. Adipocytes promote breast tumorigenesis through TAZ-dependent secretion of Resistin.
    Gao Y; Chen X; He Q; Gimple RC; Liao Y; Wang L; Wu R; Xie Q; Rich JN; Shen K; Yuan Z
    Proc Natl Acad Sci U S A; 2020 Dec; 117(52):33295-33304. PubMed ID: 33318171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunctional adipocytes promote tumor progression through YAP/TAZ-dependent cancer-associated adipocyte transformation.
    Song Y; Na H; Lee SE; Kim YM; Moon J; Nam TW; Ji Y; Jin Y; Park JH; Cho SC; Lee J; Hwang D; Ha SJ; Park HW; Kim JB; Lee HW
    Nat Commun; 2024 May; 15(1):4052. PubMed ID: 38744820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP and TAZ protect against white adipocyte cell death during obesity.
    Wang L; Wang S; Shi Y; Li R; Günther S; Ong YT; Potente M; Yuan Z; Liu E; Offermanns S
    Nat Commun; 2020 Oct; 11(1):5455. PubMed ID: 33116140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAZ Is a Negative Regulator of PPARγ Activity in Adipocytes and TAZ Deletion Improves Insulin Sensitivity and Glucose Tolerance.
    El Ouarrat D; Isaac R; Lee YS; Oh DY; Wollam J; Lackey D; Riopel M; Bandyopadhyay G; Seo JB; Sampath-Kumar R; Olefsky JM
    Cell Metab; 2020 Jan; 31(1):162-173.e5. PubMed ID: 31708444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal.
    Chai TF; Manu KA; Casey PJ; Wang M
    Oncogene; 2020 Jul; 39(31):5373-5389. PubMed ID: 32561852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TM-25659 enhances osteogenic differentiation and suppresses adipogenic differentiation by modulating the transcriptional co-activator TAZ.
    Jang EJ; Jeong H; Kang JO; Kim NJ; Kim MS; Choi SH; Yoo SE; Hong JH; Bae MA; Hwang ES
    Br J Pharmacol; 2012 Mar; 165(5):1584-94. PubMed ID: 21913895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells.
    Chan SW; Lim CJ; Guo K; Ng CP; Lee I; Hunziker W; Zeng Q; Hong W
    Cancer Res; 2008 Apr; 68(8):2592-8. PubMed ID: 18413727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-α increases breast cancer stem-like cells through up-regulating TAZ expression via the non-canonical NF-κB pathway.
    Liu W; Lu X; Shi P; Yang G; Zhou Z; Li W; Mao X; Jiang D; Chen C
    Sci Rep; 2020 Feb; 10(1):1804. PubMed ID: 32019974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties.
    Wang CH; Wang PJ; Hsieh YC; Lo S; Lee YC; Chen YC; Tsai CH; Chiu WC; Chu-Sung Hu S; Lu CW; Yang YF; Chiu CC; Ou-Yang F; Wang YM; Hou MF; Yuan SS
    Oncogene; 2018 Feb; 37(5):589-600. PubMed ID: 28991224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity.
    Cao D; Zhu GY; Lu Y; Yang A; Chen D; Huang HJ; Peng SX; Chen LW; Li YW
    Biomed Pharmacother; 2020 Sep; 129():110462. PubMed ID: 32768952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRTF/SRF dependent transcriptional regulation of TAZ in breast cancer cells.
    Liu CY; Chan SW; Guo F; Toloczko A; Cui L; Hong W
    Oncotarget; 2016 Mar; 7(12):13706-16. PubMed ID: 26885614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.
    Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA
    J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein.
    Kedan A; Verma N; Saroha A; Shreberk-Shaked M; Müller AK; Nair NU; Lev S
    Cell Death Dis; 2018 Sep; 9(10):985. PubMed ID: 30250159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting TAZ-Driven Human Breast Cancer by Inhibiting a SKP2-p27 Signaling Axis.
    Shen H; Yang N; Truskinovsky A; Chen Y; Mussell AL; Nowak NJ; Kobzik L; Frangou C; Zhang J
    Mol Cancer Res; 2019 Jan; 17(1):250-262. PubMed ID: 30237296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
    Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
    Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma.
    Li J; Li Z; Wu Y; Wang Y; Wang D; Zhang W; Yuan H; Ye J; Song X; Yang J; Jiang H; Cheng J
    Cell Death Dis; 2019 Aug; 10(8):603. PubMed ID: 31399556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LMO3 reprograms visceral adipocyte metabolism during obesity.
    Wagner G; Fenzl A; Lindroos-Christensen J; Einwallner E; Husa J; Witzeneder N; Rauscher S; Gröger M; Derdak S; Mohr T; Sutterlüty H; Klinglmüller F; Wolkerstorfer S; Fondi M; Hoermann G; Cao L; Wagner O; Kiefer FW; Esterbauer H; Bilban M
    J Mol Med (Berl); 2021 Aug; 99(8):1151-1171. PubMed ID: 34018016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclolepis genistoides D. Don (palo azul) promotes differentiation of adipocytes and regulates adipokine expression.
    Sato H; Ishikawa M; Funaki A; Kimura Y; Yoshida H; Fukata H; Hasegawa H; Ueno K
    Nutr Res; 2013 Nov; 33(11):922-31. PubMed ID: 24176232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity in Yap transgenic mice is associated with TAZ downregulation.
    Kamura K; Shin J; Kiyonari H; Abe T; Shioi G; Fukuhara A; Sasaki H
    Biochem Biophys Res Commun; 2018 Nov; 505(3):951-957. PubMed ID: 30309656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell-like Behaviors Contributing to Disease Progression.
    Hayashi H; Higashi T; Yokoyama N; Kaida T; Sakamoto K; Fukushima Y; Ishimoto T; Kuroki H; Nitta H; Hashimoto D; Chikamoto A; Oki E; Beppu T; Baba H
    Cancer Res; 2015 Nov; 75(22):4985-97. PubMed ID: 26420216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.